Back to News
Retail news

Tamiflu Label Change Ordered by FDA

The Food and Drug Administration said Roche's Tamiflu treatment for influenza must carry information warning doctors about possible psychiatric side effects from the medicine.

The RetailWire Daily

A daily briefing with the retail news, expert perspective, and business context to bring into your next meeting.

Want to know more? Learn more

Discussion Thread0